Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 2,700

• Price / Volume Information    Yesterday's Closing Price: $69.25 Daily Weekly Monthly 20 Day Moving Average: 108,390 shares Shares Outstanding: 16.48 (millions) Market Capitalization: $1,140.88 (millions) Beta: 0.42 52 Week High: $74.00 52 Week Low: $4.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 28.89% 25.51% 12 Week -3.30% -7.31% Year To Date 368.54% 309.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@multiplan.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer and Director Douglas M. Garis - Executive Vice President and Chief Financial Offic Gerald J. Kozel - Senior Vice President and Chief Accounting Officer Allen R. Thorpe - Lead Independent Director Richard A. Clarke - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/24/26 Share - Related Items Shares Outstanding: 16.48 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.42 Market Capitalization: $1,140.88 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-3.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-13.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 3.86 Price / Sales: 1.20 EPS Growth vs. Year Ago Period: -120.00% vs. Previous Quarter: -1,371.88% Sales Growth vs. Year Ago Period: 6.71% vs. Previous Quarter: 1.82% ROE 09/30/25 - -1,023.46 06/30/25 - -245.89 03/31/25 - -84.47 ROA 09/30/25 - -3.94 06/30/25 - -3.18 03/31/25 - -3.61 Current Ratio 09/30/25 - - 06/30/25 - 0.98 03/31/25 - 1.02 Quick Ratio 09/30/25 - - 06/30/25 - 0.98 03/31/25 - 1.02 Operating Margin 09/30/25 - -21.14 06/30/25 - -17.51 03/31/25 - -20.72 Net Margin 09/30/25 - -35.93 06/30/25 - -70.91 03/31/25 - -126.96 Pre-Tax Margin 09/30/25 - - 06/30/25 - -83.12 03/31/25 - -140.05 Book Value 09/30/25 - - 06/30/25 - -2.42 03/31/25 - 0.90 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - 310.26 Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - 99.68

Powered by Zacks Investment Research ©